Summit Therapeutics Inc. — Investor Relations & Filings
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for serious unmet medical needs, with a primary focus on oncology. The company's mission is to improve the quality and potential duration of life for patients. Its lead product candidate is ivonescimab (SMT112), a novel bispecific antibody that targets both PD-1 and VEGF. Summit is advancing ivonescimab through multiple global Phase III clinical trials to treat various solid tumors, with a significant emphasis on non-small cell lung cancer (NSCLC). The company's strategy centers on developing innovative treatments that can provide substantial benefits for patients, physicians, and caregivers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-30 | English | |
| DEF 14A - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-17 | English | |
| 10-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | |
| 8-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | |
| 8-K Filing | 2026-01-29 | English | |
| FORM 4 | 2026-01-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39226506 | 10-Q - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-30 | English | ||
| 34662077 | DEF 14A - Summit Therapeutics Inc. (0001599298) (Filer) | 2026-04-17 | English | ||
| 32894822 | 10-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | ||
| 32894821 | 8-K - SUMMIT THERAPEUTICS INC. (0001599298) (Filer) | 2026-02-23 | English | ||
| 30827049 | 8-K Filing | 2026-01-29 | English | ||
| 12749857 | FORM 4 | 2026-01-12 | English | ||
| 12749858 | 8-K | 2026-01-12 | English | ||
| 12749859 | FORM 4 | 2026-01-07 | English | ||
| 12749860 | FORM 4 | 2026-01-07 | English | ||
| 12749861 | FORM 4 | 2026-01-07 | English | ||
| 12749862 | FORM 4 | 2026-01-07 | English | ||
| 12749863 | FORM 4 | 2026-01-07 | English | ||
| 12749864 | FORM 4 | 2026-01-07 | English | ||
| 12749865 | FORM 4 | 2026-01-07 | English | ||
| 12749866 | FORM 4 | 2026-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
Summit Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30436/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30436 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30436 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30436 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30436}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Summit Therapeutics Inc. (id: 30436)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.